| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,064 |
14,745 |
$536K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
9,426 |
1,675 |
$206K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,424 |
2,172 |
$72K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
793 |
789 |
$47K |
| 99223 |
Prolong inpt eval add15 m |
636 |
625 |
$37K |
| 62323 |
|
158 |
158 |
$28K |
| 99233 |
Prolong inpt eval add15 m |
580 |
237 |
$20K |
| 99222 |
Initial hospital care, per day, moderate complexity |
499 |
485 |
$20K |
| 64493 |
|
104 |
56 |
$14K |
| 99072 |
|
736 |
625 |
$13K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,216 |
1,185 |
$7K |
| 77002 |
|
135 |
131 |
$6K |
| J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
111 |
110 |
$5K |
| 64495 |
|
103 |
55 |
$4K |
| 64494 |
|
104 |
56 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
76 |
72 |
$2K |
| J3490 |
Unclassified drugs |
192 |
184 |
$2K |
| 20610 |
|
34 |
27 |
$1K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
136 |
131 |
$885.92 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
674 |
665 |
$826.97 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
48 |
48 |
$259.49 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
27 |
27 |
$81.07 |